Search

everythinglearnresearchcommunity

for

Search:↓

High LGR5 levels in glioblastoma indicate poor prognosis and are essential for cancer stem cell survival.

Coinheritance of BRCA2 and CYLD genes may lead to new treatment options for certain cancers.

The research found that a protein called caveolin-1 is reduced in psoriasis, but reintroducing it can help alleviate some psoriasis symptoms.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

The document concluded that certain compounds might strongly bind to and potentially inhibit a key SARS-CoV-2 protein, but further testing is needed.

BTNL proteins help control inflammatory bowel disease by maintaining specific immune cells.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

Cepharanthine may help treat COVID-19 by targeting multiple pathways.

CVP therapy showed moderate success in treating advanced non-Hodgkin's lymphoma, but more intensive treatment is needed for better outcomes.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

A man with Cronkhite-Canada syndrome improved significantly with immunosuppressive therapy.

Some synthetic carbohydrate receptors, especially compounds 3 and 15, show strong potential for treating Zika virus.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

Targeting ACE2 and TMPRSS2 may help prevent or treat COVID-19 in cancer patients.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

Certain antiparasitics and antidepressants show promise for treating cryptococcosis, especially when combined with fluconazole.

Risankizumab may help manage symptoms of dissecting cellulitis of the scalp.

A prostate cancer drug can lower the levels of a protein that the coronavirus uses to enter lung cells.

ICL is a condition with low CD4+ T cells like AIDS but not caused by HIV, and normal CD4+ T cell counts may vary between men and women.

A 16-year-old boy with Castleman's disease and lupus was successfully treated and showed no recurrence.

Targeting NMMHC IIA may help treat blood-brain barrier damage.

Ocrelizumab may cause pancreatitis in some patients.

Lack of Crif1 in hair follicle stem cells slows down hair growth in mice.

CD19-CAR T cell therapy may help regenerate skin in systemic sclerosis.

CCCA may be a fibroproliferative disorder, and anti-fibrotic therapies could help.

Thalidomide works best for skin lupus not helped by antimalarials, but has many side effects; other treatments are less effective, especially if patients also have systemic lupus.

A 60-year-old man with Cronkhite-Canada syndrome improved with treatment, but the condition has a high mortality rate and a risk of colorectal cancer.

Intralesional cidofovir may be a viable alternative treatment for SCC.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.